JELÍNEK, Tomáš, Renata BEZDĚKOVÁ, M ZÁTOPKOVÁ, L BURGOS, M SIMICEK, T SEVCIKOVA, B PAIVA a Roman HÁJEK. Current applications of multiparameter flow cytometry in plasma cell disorders. Blood Cancer Journal. LONDON: NATURE PUBLISHING GROUP, 2017, roč. 7, 12 s. ISSN 2044-5385. Dostupné z: https://dx.doi.org/10.1038/bcj.2017.90.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Current applications of multiparameter flow cytometry in plasma cell disorders
Autoři JELÍNEK, Tomáš, Renata BEZDĚKOVÁ, M ZÁTOPKOVÁ, L BURGOS, M SIMICEK, T SEVCIKOVA, B PAIVA a Roman HÁJEK.
Vydání Blood Cancer Journal, LONDON, NATURE PUBLISHING GROUP, 2017, 2044-5385.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 8.125
Doi http://dx.doi.org/10.1038/bcj.2017.90
UT WoS 000413469800001
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Renata Bezděková, Ph.D., učo 324025. Změněno: 6. 2. 2019 11:56.
Anotace
Multiparameter flow cytometry (MFC) has become standard in the management of patients with plasma cell (PC) dyscrasias, and could be considered mandatory in specific areas of routine clinical practice. It plays a significant role during the differential diagnostic workup because of its fast and conclusive readout of PC clonality, and simultaneously provides prognostic information in most monoclonal gammopathies. Recent advances in the treatment and outcomes of multiple myeloma led to the implementation of new response criteria, including minimal residual disease (MRD) status as one of the most relevant clinical endpoints with the potential to act as surrogate for survival. Recent technical progress led to the development of next-generation flow (NGF) cytometry that represents a validated, highly sensitive, cost-effective and widely available technique for standardized MRD evaluation, which also could be used for the detection of circulating tumor cells. Here we review current applications of MFC and NGF in most PC disorders including the less frequent solitary plasmocytoma, light-chain amyloidosis or Waldenstrom macroglobulinemia.
VytisknoutZobrazeno: 27. 4. 2024 20:52